FDA Inspection 885683 — Orgapharm

Orgapharm — FEI 3002807503

The FDA completed an inspection of Orgapharm on May 23, 2014 in Pithiviers. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
May 23, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pithiviers (France)